Compare Kencana Energi Lestari Tbk (KEEN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kencana Energi Lestari Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Kencana Energi Lestari Tbk trades at Rp920 (market cap 3.45T, 7.05M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kencana Energi Lestari Tbk is far larger — about 33× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KEEN | SCPI | |
|---|---|---|
Market Cap | 3.45T | 104.4B |
Volume | 7.05M | — |
Lot | 70.5K | — |
Turnover | 6.49B | — |
Average Price | 920.52 | — |
Value | 6.49B | — |
Indicative Equilibrium Price | 920 | — |
Indicative Equilibrium Volume | 243 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kencana Energi Lestari Tbk
PT Kencana Energi Lestari Tbk (the “Company”) was established in the Republic of Indonesia originally under the name of “PT Citra Alam Pratama” on May 5, 2008 based on Notarial Deed No. 1 of Ir. Rusli, S.H.
Read more on KEEN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
